Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model01:12

One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

386
Extravascular administration, such as oral or intramuscular routes, is a non-invasive drug delivery method, often preferred for ease and patient compliance. A key factor here is absorption, which dictates how quickly and effectively the drug enters the bloodstream from the administration site. Absorption follows either zero-order or first-order kinetics.
Zero-order absorption maintains a steady rate irrespective of the amount of drug left to be absorbed, making it a constant process. In the...
386
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

687
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
687
One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model01:15

One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

568
The first-order absorption model for extravascular administration describes the rate at which a drug is absorbed and eliminated, following the principles of first-order kinetics. This model is vital as it provides a mathematical representation of drug behavior within the body. It also allows for the prediction and interpretation of drug absorption and elimination based on the rate of change in drug concentration over time. This model can be visualized as a plasma concentration-time profile...
568
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

1.2K
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
1.2K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

210
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
210
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

759
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
759

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic toxicity and immunotoxicity studies of glucose oxidase-loaded extracellular vesicles derived from lung cancer cells.

Frontiers in immunology·2026
Same author

Magnetic thermoradiotherapy for lung cancer: evaluation in A549-based preclinical models.

Frontiers in oncology·2026
Same author

Extracellular vesicles delivering TIMP-2 modulate MMP-1, MMP-2, and MMP-9 expression in human lung adenocarcinoma A549 cells.

Frontiers in pharmacology·2026
Same author

Translating magnetic fluid hyperthermia toward lung cancer treatment.

Nanoscale·2026
Same author

Neural stem cell quiescence is actively maintained by the epigenome.

Cell reports·2025
Same author

Dynamic Susceptibility Contrast Magnetic Resonance Imaging with Carbon-Encapsulated Iron Nanoparticles Navigated to Integrin Alfa V Beta 3 Receptors in Rat Glioma.

Nanomaterials (Basel, Switzerland)·2025
Same journal

TELEVISION ADVERTISING OF SELECTED MEDICINAL PRODUCTS IN POLAND AND IN THE UNITED STATES - A COMPARATIVE ANALYSIS OF SELECTED TELEVISION COMMERCIALS.

Acta poloniae pharmaceutica·2018
Same journal

EFFECT OF DIETARY FLAVONOID NARINGENIN ON BONES IN RATS WITH OVARIECTOMY-INDUCED OSTEOPOROSIS.

Acta poloniae pharmaceutica·2018
Same journal

EXCRETION OF ETHYL GLUCURONIDE IN THE URINE OF WARSAW HIGH PREFERRING RATS DEPENDS ON THE CONCENTRATION OF INGESTED ETHANOL.

Acta poloniae pharmaceutica·2018
Same journal

PREPARATION AND EVALUATION OF pH RESPONSIVE POLY(2-HYDROXYETHYL METHACRYLATE-CO-ITACONIC ACID) MICROGELS FOR CONTROLLED DRUG DELIVERY.

Acta poloniae pharmaceutica·2018
Same journal

FORMULATION, EVALUATION AND IN VITRO DISSOLUTION PERFORMANCE OF ENALAPRIL MALEATE SUSTAINED RELEASE MATRICES: EFFECT OF POLYMER COMPOSITION AND VISCOSITY GRADE.

Acta poloniae pharmaceutica·2018
Same journal

EFFECT OF SIMULTANEOUSLY SILICIFIED MICROCRYSTALLINE CELLULOSE AND PREGELATINIZED STARCH ON THE THEOPHYLLINE TABLETS STABILITY.

Acta poloniae pharmaceutica·2018
See all related articles

Related Experiment Video

Updated: Feb 12, 2026

Manual Restraint and Common Compound Administration Routes in Mice and Rats
14:10

Manual Restraint and Common Compound Administration Routes in Mice and Rats

Published on: September 26, 2012

300.9K

QUINIDINE AND DOMPERIDONE INTERACTIONS IN THE RAT EXPERIMENTAL MODEL OF REPEATED ADMINISTRATION.

Magdalena Bamburowicz-Klimkowska, Tadeusz Szost, Anna Małkowska

    Acta Poloniae Pharmaceutica
    |April 13, 2018
    PubMed
    Summary
    This summary is machine-generated.

    This study shows that quinidine alters domperidone absorption and metabolism in rats. Quinidine

    More Related Videos

    Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats
    09:25

    Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats

    Published on: July 22, 2010

    18.0K
    Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
    09:14

    Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

    Published on: June 18, 2021

    2.9K

    Related Experiment Videos

    Last Updated: Feb 12, 2026

    Manual Restraint and Common Compound Administration Routes in Mice and Rats
    14:10

    Manual Restraint and Common Compound Administration Routes in Mice and Rats

    Published on: September 26, 2012

    300.9K
    Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats
    09:25

    Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats

    Published on: July 22, 2010

    18.0K
    Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
    09:14

    Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

    Published on: June 18, 2021

    2.9K

    Area of Science:

    • Pharmacokinetics
    • Drug Interactions
    • Toxicology

    Background:

    • Domperidone (DOM) and quinidine (QD) interactions are complex, potentially involving P-glycoprotein (P-gp) inhibition and cytochrome P450 metabolism.
    • Understanding these interactions is crucial for safe and effective drug use.

    Purpose of the Study:

    • To investigate the pharmacokinetic interaction between domperidone and quinidine in a Wistar rat model.
    • To elucidate the effects of quinidine on domperidone absorption and metabolism.

    Main Methods:

    • Repeated oral administration of domperidone (30 mg/kg) with and without quinidine (25 mg/kg) to Wistar rats.
    • Acetaminophen (30 mg/kg) was co-administered to assess gastric emptying.
    • Plasma concentrations of domperidone and acetaminophen were quantified using High-Performance Liquid Chromatography (HPLC).

    Main Results:

    • Quinidine prolonged gastric emptying time, indicating anticholinergic effects.
    • Co-administration with quinidine increased domperidone plasma concentrations, particularly with later doses.
    • Analysis suggested initial enhancement of domperidone absorption followed by inhibition of hepatic biotransformation, leading to a 2-3 fold increase in overall exposure (AUC(0-6)).

    Conclusions:

    • Quinidine significantly impacts domperidone pharmacokinetics through both absorption and metabolism pathways.
    • The observed interactions highlight the importance of considering co-administered drugs like quinidine when using domperidone.
    • Further research is warranted to fully understand the clinical implications of this drug interaction.